Linkage of human narcolepsy with HLA association to chromosome 4p13-q21

Genomics

Volumn 65, Issue 1, 2000, Pages 84-86

  Nakayama, Junko ^a   Miura, Miki ^a   Honda, Makoto ^b   Miki, Tetsuro ^c   Honda, Yutaka ^d   Arinami, Tadao ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b TOKYO METROPOLITAN MATSUZAWA HOSPITAL   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN;

ARTICLE; CHROMOSOME 4P; CHROMOSOME 4Q; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; GENETIC LINKAGE; HLA SYSTEM; HUMAN; MALE; NARCOLEPSY; PRIORITY JOURNAL; SLEEP DISORDER;

EID: 0034176716     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.2000.6143     Document Type: Article

References (21)

1. Billiard M., Pasquie-Magnetto V., Heckman M., Carlander B., Besset A., Zachariev Z., Eliaou J. F., Malafosse A. Family studies in narcolepsy. Sleep. 17:1994;S54-59.
2. Carlander B., Eliaou J. F., Billiard M. Autoimmune hypothesis in narcolepsy. Neurophysiol. Clin. 23:1993;15-22.
3. Chemelli R. M., Willie J. T., Sinton C. M., Elmquist J. K., Scammell T., Lee C., Richardson J. A., Williams S. C., Xiong Y., Kisanuki Y., Fitch T. E., Nakazato M., Hammer R. E., Saper C. B., Yanagisawa M. Narcolepsy in orexin knockout mice: Molecular genetics of sleep regulation. Cell. 98:1999;437-451.
4. Diagnostic Classification Steering Committee (Thorpy, M. J., Chairman) 1990. International Classification of Sleep Disorders. Diagnostic and Coding Manual. American Sleep Disorders Association, Rochester, MN.
5. Fredrikson S., Carlander B., Billiard M., Link H. CSF immune variables in patients with narcolepsy. Acta Neurol. Scand. 81:1990;253-254.
6. Guilleminault C., Mignot E., Grumet F. C. Familial patterns of narcolepsy. Lancet. 2:1989;1376-1379.
7. Honda Y. Consensus of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa City. Sleep Res. 12:1979;254.
8. Honda Y. Clinical features of narcolepsy: Japanese experiences. Honda Y., Juji T. HLA in Narcolepsy. 1988;24-57 Springer-Verlag, Berlin.
9. Honda Y., Asaka A., Tanaka Y., Juji T. Discrimination of narcolepsy by using genetic markers and HLA. Sleep Res. 12:1983;254.
10. Honda Y., Matsuki K. Genetic aspects of narcolepsy. Thorpy M. J. Handbook of Sleep Disorders. 1990;217-234 Dekker, New York.
11. Honda Y., Takahashi Y., Honda M., Watanabe Y., Sato T., Miki T., Kuwata S., Tokunaga K., Juji T. Genetic aspects of narcolepsy. Hayaishi O., Inoue S. Sleep and Sleep Disorders from Molecule to Behavior. 1997;341-358 Academic Press, Tokyo.
12. Kong A., Cox N. J. Allele-sharing models: LOD scores and accurate linkage tests. Am. J. Hum. Genet. 61:1997;1179-1188.
13. Kruglyak L., Daly M. J., Reeve-Daly M. P., Lander E. S. Parametric and nonparametric linkage analysis: A unified multipoint approach. Am. J. Hum. Genet. 58:1996;1347-1363.
14. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., Qiu X., de Jong P. J., Nishino S., Mignot E. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 98:1999;365-376.
15. Matsuki K., Grumet F. C., Lin X., Gelb M., Guilleminault C., Dement W. C., Mignot E. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet. 339:1992;1052.
16. Matsuki K., Juji T., Honda Y. No male segregation distortion of DR2 haplotypes in Japanese narcoleptic patients. Hum. Immunol. 23:1988;23-26.
17. Mignot E. Genetics of narcolepsy and other sleep disorders. Am. J. Hum. Genet. 60:1997;1289-1302.
18. Mignot E. Genetic and familial aspects of narcolepsy. Neurology. 50:1998;S16-S22.
19. Mignot E., Tafti M., Dement W. C., Grumet F. C. Narcolepsy and immunity. Adv. Neuroimmunol. 5:1995;23-37.
20. Rogers A. E., Meehan J., Guilleminault C., Grumet F. C., Mignot E. HLA DR15 (DR2) and DQB1*0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology. 48:1997;1550-1556.
21. Tafti M., Nishino S., Aldrich M. S., Liao W., Dement W. C., Mignot E. Major histocompatibility class II molecules in the CNS: Increased microglial expression at the onset of narcolepsy in canine model. J. Neurosci. 16:1996;4588-4595.